Viridian Therapeutics, Inc.
VRDNNASDAQHealthcare● Active
$15.73
$-0.05(-0.32%)
Market Cap$1.4B
P/E Ratio—
52W High$34.29
52W Low$13.18
Viridian Therapeutics, Inc.（VRDN）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · VRDN · 截至 2026-06-08
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $70.85M | $0.30M | $0.31M | $1.77M | $2.96M |
| Cost of Revenue | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Gross Profit | $70.85M | $0.30M | $0.31M | $1.77M | $2.96M |
| Gross Margin %(computed) | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| Operating Expenses | |||||
| R&D Expenses | $338.93M | $238.25M | $159.76M | $100.89M | $56.89M |
| G&A Expenses | $95.31M | $61.08M | $95.00M | $35.18M | $25.80M |
| Total Operating Expenses | $434.24M | $299.34M | $254.76M | $136.08M | $82.69M |
| Operating Income | ($363.39M) | ($299.04M) | ($254.45M) | ($134.30M) | ($79.73M) |
| Operating Margin %(computed) | -512.91% | — | — | — | — |
| Interest Income | $27.40M | $32.13M | $18.56M | $4.92M | $0.32M |
| Interest Expense | $4.95M | $3.05M | $1.85M | $0.49M | $0.00M |
| Income Before Tax | ($342.60M) | ($269.95M) | ($237.73M) | ($129.87M) | ($79.41M) |
| Income Tax Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Income | ($342.60M) | ($269.95M) | ($237.73M) | ($129.87M) | ($79.41M) |
| Net Margin %(computed) | -483.57% | — | — | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-3.32 | $-3.98 | $-5.31 | $-3.91 | $-6.66 |
| Wtd Avg Shares | 84.80M | 67.89M | 44.76M | 32.09M | 11.92M |
| EBITDA | ($337.19M) | ($265.66M) | ($235.37M) | ($129.13M) | ($79.29M) |
| EBITDA Margin %(computed) | -475.93% | — | — | — | — |
数据来源：Financial Modeling Prep · 最后更新：2026-06-08 · USD · M
深入了解Viridian Therapeutics, Inc.
关于Viridian Therapeutics, Inc.（VRDN）损益表
Viridian Therapeutics, Inc.（VRDN）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，VRDN实现营收$0.07B，毛利润$0.07B（毛利率100.00%），净利润($0.34B)（净利率-483.57%）。
常见问题
VRDN · 4 问Viridian Therapeutics, Inc.（VRDN）2025财年营收为$0.07B，同比up23359.9%。
VRDN revenueVRDN salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08